Filing Flows

Filing Flows › Companies › Healthy Extracts › Cash flow

Healthy Extracts cash flow, quarter by quarter

Latest: Q2 2026 · from the cash-flow statements filed with the SEC

Free cash flow$306K in Q2 2026 · $500K over twelve months

Operating cash flow$306K
Free cash flow+$306K
Cash conversion cycle69 days

Analysis

In Q2 2026, Healthy Extracts generated $306K of operating cash flow. That is $289K more than in Q2 2025 ($17K).

Over the twelve months to Jun 30, 2026, operating cash flow was $500K; the largest uses were other financing ($998K); besides operations, cash came from net borrowing (+) / repaid (−) ($316K), other investing ($172K); the cash balance fell by $11K.

Operating cash flow was $306K against net income of −$129K. The largest differences: inventory −$667K, accrued liabilities +$276K, receivables −$138K.

Its cash conversion cycle was 69 days (receivables 19 + inventory 86 − payables 36).

Free cash flow

Healthy Extracts: free cash flow by quarterHealthy Extracts: free cash flow by quarter$52KQ3 2024$42KQ4 2024$60KQ1 2025$17KQ2 2025−$280KQ3 2025$368KQ4 2025$106KQ1 2026$306KQ2 2026
Operating cash flow less capital spending.
Healthy Extracts: operating cash flow against capital spendingHealthy Extracts: operating cash flow against capital spendingOperating cash flowCapital spending$52K$0Q3 2024$42K$0Q4 2024$60K$0Q1 2025$17K$0Q2 2025−$280K$0Q3 2025$368K$0Q4 2025$106K$0Q1 2026$306K$0Q2 2026
Latest (Q2 2026): Operating cash flow $306K, Capital spending $0.

Capital allocation, year by year

Healthy Extracts: where the cash came from (up) and went (down), by fiscal yearHealthy Extracts: where the cash came from (up) and went (down), by fiscal yearOperating cash flowNet borrowingShares issuedAsset salesCapital spendingFY2021: Operating cash flow −$901KFY2021: Net borrowing $165KFY2021: Shares issued $995K$1.2MFY2021FY2022: Operating cash flow −$391KFY2022: Net borrowing $146KFY2022: Shares issued −$11KFY2022: Asset sales $3KFY2022: Capital spending −$8K$148KFY2022FY2023: Operating cash flow −$416KFY2023: Net borrowing $363KFY2023: Shares issued −$90K$363KFY2023FY2024: Operating cash flow $282K$282KFY2024FY2025: Operating cash flow $166KFY2025: Net borrowing $160K$326KFY2025
Over these 5 years operating cash flow totalled −$1.3M; the largest uses were operating cash flow ($1.7M) and shares issued ($101K). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$190K
Debtnone
Net cash$190K

Healthy Extracts funds itself: free cash flow was $500K over the last twelve months, with $190K of cash and investments and no debt on the balance sheet.

Where the cash came from and went

Healthy Extracts: sources (+) and uses (−) of cash, Q2 2026Healthy Extracts: sources (+) and uses (−) of cash, Q2 2026Other financing−$516KOperating cash flow$306KNet borrowing (+) / repaid (−)$140KOther investing$96KCash drawn (+) / kept (−)−$26K
Healthy Extracts: sources (+) and uses (−) of cash, TTM to Q2 2026Healthy Extracts: sources (+) and uses (−) of cash, TTM to Q2 2026Other financing−$998KOperating cash flow$500KNet borrowing (+) / repaid (−)$316KOther investing$172KCash drawn (+) / kept (−)$11K

From profit to cash

Healthy Extracts: net income to operating cash flow, Q2 2026Healthy Extracts: net income to operating cash flow, Q2 2026Net income−$129KReceivables−$138KInventory−$667KPayables$18KAccrued liabilities$276KOperating cash flow$306K
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
QuarterReceivable daysInventory daysPayable daysCash conversion cycle
Q2 202619863669
Q1 202612991992
Q4 2025611314105
Q3 2025220323181
Q2 2025327224252
Q1 2025422312215
Q4 2024236112350
Q3 2024789031866

Every quarter

QuarterOperating cash flowNet borrowing (+) / repaid (−)Cash drawn (+) / kept (−)Free cash flow
Q2 2026$306K$140K−$26K$306K
Q1 2026$106K$176K−$17K$106K
Q4 2025$368K—$43K$368K
Q3 2025−$280K—$11K−$280K
Q2 2025$17K—−$82K$17K
Q1 2025$60K—−$7K$60K
Q4 2024$42K−$26K−$12K$42K
Q3 2024$52K—$48K$52K

Healthy Extracts: income statement and cash flow

Healthy Extracts, Q2 2026: revenue $2.1M (+113% year over year), operating margin -6.3%. The chart follows the revenue to costs, profit and cash.

Healthy Extracts: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.